FIELD: medicine, valvular cardioprosthetics. SUBSTANCE: biotissue for xenoprosthetics should be kept in 1-10-% hypertonic solution of sodium chloride before fermentative treatment, treated with enzyme in borate buffer solution at 32-37 C, washed in, firstly, 0.6-6-% acetic acid solution, then in sodium hydrocarbonate solution and sodium chloride solutions, kept in multi-substituted solution of glutaric aldehyde in buffer solution at increasing concentration and sterilized. The invention favors to shorten expenses of expensive reagents and decrease possibility for biotissue mineralization. EFFECT: higher efficiency. 1 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR MODIFYING BIOTISSUE FOR PROSTHETIC REPAIR | 2012 |
|
RU2523879C2 |
METHOD OF PREPARING BIOTISSUE FOR XENOPROSTHESIS | 1999 |
|
RU2151505C1 |
METHOD FOR MAKING PLATE FROM MODIFIED XENOGENEIC ENTERAL SUBMUCOSA | 2013 |
|
RU2542432C1 |
DISINFECTING-DETERGENT SOLUTION | 2000 |
|
RU2173337C1 |
DISINFECTING AGENT | 1999 |
|
RU2145238C1 |
METHOD OF PROCESSING GRAFTS FOR CARDIOVASCULAR SURGERY USING SUB- AND SUPERCRITICAL CARBON DIOXIDE | 2022 |
|
RU2796364C1 |
SORBENT AND METHOD FOR ITS PRODUCTION | 1996 |
|
RU2094117C1 |
METHOD FOR PREPARING COLLAGEN FOR TREATMENT OF PATHOLOGY OF BODY TISSUES | 2002 |
|
RU2214827C1 |
METHOD FOR MANUFACTURING BIOPROSTHESIS OF CARDIAC VALVE | 2003 |
|
RU2238061C1 |
BIOABSORBABLE COLLAGEN MATRIX, METHOD OF PRODUCTION AND APPLICATION | 2007 |
|
RU2353397C2 |
Authors
Dates
2003-02-10—Published
2001-06-09—Filed